Mersana Therapeutics Inc. (MRSN)
Mersana Therapeutics Statistics
Share Statistics
Mersana Therapeutics has 124.63M shares outstanding. The number of shares has increased by 1.86% in one year.
| 124.63M |
| 1.86% |
| 0.89% |
| 84.99% |
| n/a |
| 5,812 |
| 0.2% |
Short Selling Information
The latest short interest is 12.78M, so 10.26% of the outstanding shares have been sold short.
| 12.78M |
| 10.26% |
| 11.2% |
| 5.6 |
Valuation Ratios
The PE ratio is -2.53 and the forward PE ratio is -0.62. Mersana Therapeutics's PEG ratio is 0.04.
| -2.53 |
| -0.62 |
| 4.33 |
| 0.1 |
| -18.43 |
| -2.12 |
| 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mersana Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of -3.01.
| 2.19 |
| 2.19 |
| -3.01 |
| -0.45 |
| -0.35 |
| -18.93 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $397,029.41 |
| $-678,352.94 |
| 102 |
| 0.28 |
| n/a |
Taxes
| 418K |
| -0.61% |
Stock Price Statistics
The stock price has increased by -83.78% in the last 52 weeks. The beta is 0.82, so Mersana Therapeutics's price volatility has been higher than the market average.
| 0.82 |
| -83.78% |
| 0.35 |
| 1.18 |
| 50.9 |
| 2,857,385 |
Income Statement
In the last 12 months, Mersana Therapeutics had revenue of 40.5M and earned -69.19M in profits. Earnings per share was -0.56.
| 40.5M |
| 40.5M |
| -73.34M |
| -69.19M |
| -63.27M |
| -64.9M |
| -0.56 |
Balance Sheet
The company has 107.75M in cash and 28.6M in debt, giving a net cash position of 79.15M.
| 107.75M |
| 28.6M |
| 79.15M |
| -895.55M |
| 112.47M |
| 48.03M |
Cash Flow
In the last 12 months, operating cash flow was -82.34M and capital expenditures -132K, giving a free cash flow of -82.47M.
| -82.34M |
| -132K |
| -82.47M |
| -0.67 |
Margins
Gross margin is 100%, with operating and profit margins of -181.09% and -170.86%.
| 100% |
| -181.09% |
| -169.82% |
| -170.86% |
| -156.24% |
| -181.09% |
| -203.65% |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for MRSN is $5, which is 1288.9% higher than the current price. The consensus rating is "Buy".
| $5 |
| 1288.9% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -12.5 |
| 2 |